ISPOR Issue Panels and Workshops Featuring Insight on RWD and Healthcare Outcomes
ISPOR Europe will take place December 1st – 3rd, this year in a virtual format. The Issue Panels and Workshop [...]
ICER Whitepaper on Successfully Navigating the FDA’s Accelerated Approval Pathway
Today, ICER (the Institute for Clinical and Economic Review) announced a new whitepaper on understanding and navigating the FDA’s accelerated [...]
Seqster Develops Streamlined Patient Healthcare Platform, Raises $12 Million in Funding
Data aggregator Seqster has raised $12 million in startup funding. The company offers a single platform for EHR (electronic health [...]
Will Patient RWD Improve Cardiovascular Disease Outcomes?
Amgen and Datos Health have partnered to explore how RWD (real world data) can improve outcomes for heart disease patients. Using [...]
2021 Healthcare Trends Report Now Available, Includes Telehealth and Health Equity Discussion
Healthcare Industry Network has announced its annual report on the state of healthcare as the COVID-19 pandemic continues to affect [...]
FDA to Discuss Fates of Half a Dozen Cancer Drugs Next Week
The Food and Drug Administration has set a three-day meeting from April 27th to the 29th where a host of [...]
Cytel Scientist Discusses Clinical Trial Statistical Success Strategies
Cytel scientist Dr. Yannis Jemiai discusses important statistical considerations critical for clinical trial success. Communication at all levels of the [...]
ISPOR Editors Discuss Challenges in HEOR Publishing
Value in Health editors-in-Chief Zeba Khan and Laura Pizzi discuss the challenges associated with publishing HEOR research and the day-to-day [...]
Federal Agency Proposes Penalties if Pharma Forgoes Clinical Trials
The Medicaid and CHIP Payment and Access Commission has voted to demand pharma companies pay higher Medicaid rebates if they [...]
Webinar on Digital Healthcare Trends and Shift to Value-Based Care
A new on-demand webinar discusses healthcare trends for the next decade, with a clear comprehensive picture of the healthcare landscape [...]
New Syneos Health and Medable Partnership Aimed at Streamlining Clinical Trials
Syneos Health has announced a partnership with Medable, a well-known cloud platform in drug development. The partnership will improve clinical [...]
New eBook on Improving Patient-Centered Healthcare Using RWD
A new eBook offered by Optum discusses when it’s appropriate to use RWD (real world data) to improve healthcare outcomes. [...]
New Study Highlights Impact of Women Leaders Throughout Companies
As women have been promoted to top-level positions, positive consequences including more profitable companies and better customer experiences have been [...]
Will Biden Budget Tackle Drug Pricing?
The Biden administration has announced its skinny budget. One major omission was any mention of drug pricing regulation. However, the [...]
Virtual Congress Trends Will Continue After COVID-19
As the COVID-19 pandemic led to healthcare conferences being shut down, virtual events became the standard. Healthcare professionals have continued [...]
West Virginia Takes Legislative Action to Lower Drug Costs, Improve Health Equity
West Virginia passed a law that will compel payers and PBMs (Pharmacy Benefit Managers) to pass on medication savings to [...]
HealthVerity Offers Webinar on HEOR and RWD
HealthVerity will offer a webinar on Wednesday, May 5th at 1:00 PM EDT. Speakers will discuss how to effectively use [...]
Humana Introduces Program Aimed at Managing Chronic Disease Using RWD and Analytics
Humana has announced Humana Care Support, a program aimed at helping elderly people in managing their chronic disease(s). The program [...]
ISPOR General Business Meeting to Take Place on May 26th
ISPOR will hold a virtual General Business Meeting on May 26th from 9:00 AM to 9:45 AM EDT. The session [...]
New ISPOR Value in Health Article on Applying HEOR to the COVID-19 Pandemic
A new editorial article published in ISPOR’s Value in Health journal discusses the positive and negative consequences pharmaceutical and nonpharmaceutical [...]
New Report on Utilizing RWE in Drug Development Pipeline Throughout the Globe
A new report by consulting group Roots Analysis has been published. It features insight on RWE (real world evidence) when [...]
New FDA Drug Director Appointment Announced, FDA Commissioner Role Remains Open
Patricia Cavazzoni will serve as director of the US Food & Drug Administration’s CDER (Center for Drug Evaluation and Research). [...]
HEOR Experts Release Recommendations to Spur Volume-to-Value Shift and Improve Healthcare Equity
Researchers at the Leonard Davis Institute of Health Economics at the University of Pennsylvania have released a set of recommendations [...]
Maine Citizens Demand Prescription Drug Pricing Action in Public Hearing; 219,000 Mainers Can’t Afford Medication
Maine recently held a public meeting where Mainers discussed how skyrocketing drug prices lead to extreme financial hardship, pain, and [...]
ICER and Aetion Collaborate to Use RWE in Hereditary Angioedema Pilot Study
ICER recently announced a partnership with Aetion. ICER will use Aetion’s RWE (real world evidence) in revising its assessment on [...]